Kilitch Drugs India Q3 Results

  • BSE: 524500
  • NSE: KILITCH
  • ISIN: INE729D01010
  • Sector: Biotechnology & Drugs
BSE
306.6-2.45 (-0.79%)
Volume895.00
Updated: Mon 25 Nov, 2024 | 15:28:12
NSE
307.45-2.60 (-0.84%)
Volume7.09 K
Updated: Mon 25 Nov, 2024 | 15:31:32
Today: 306.60
316.25
52-Wk: 298.45
469.85

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Kilitch Drugs India Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 31.7941.20-%29.97-%
    Selling/ General/ Admin Expenses Total 2.512.61-%2.98-%
    Depreciation/ Amortization 0.810.82-%0.93-%
    Other Operating Expenses Total 7.067.08-%7.18-%
    Total Operating Expense 30.3333.40-%26.92-%
    Operating Income 1.477.80-%3.05-%
    Net Income Before Taxes 2.826.78-%2.45-%
    Net Income 2.914.74-%2.37-%
    Diluted Normalized EPS 1.852.93-%1.52-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts